QSM Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$16M Hold
559,438
– – 6.59% 2
2026
Q2
$13.5M Buy
559,438
+67,800
+14% +$1.77M 6.98% 2
2026
Q1
$13.7M Sell
491,638
-15,205
-3% -$405K 6.73% 2
2025
Q4
$12.6M Buy
506,843
+46,100
+10% +$1.16M 7.22% 4
2025
Q3
$11.3M Buy
460,743
+276,899
+151% +$6.83M 8.06% 5
2025
Q2
$4.47M Sell
183,844
-220,958
-55% -$5.15M 4.11% 13
2025
Q1
$10.1M Buy
404,802
+138,000
+52% +$3.61M 7.6% 1
2024
Q4
$7.05M Buy
+266,802
New +$7.24M 6.06% 7

Other funds holding PFE

QSM Asset Management's PFE Position: Q3 2026 in Review

QSM Asset Management held its Pfizer (PFE) position steady in Q3 2026 at 559,438 shares worth $16M. The position accounts for 6.59% of the portfolio, ranked #2.

QSM Asset Management first reported a position in PFE in Q4 2024 and has held it in 8 quarters since. 2,208 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • QSM Asset Management held 559,438 shares of Pfizer worth $16M as of Q3 2026.
  • QSM Asset Management left its Pfizer share count unchanged in Q3 2026.
  • Pfizer made up 6.59% of QSM Asset Management's portfolio in Q3 2026, its #2 holding.
  • QSM Asset Management first reported a position in Pfizer in Q4 2024 and has held it in 8 quarters since.
  • 2,208 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on QSM Asset Management's 13F filing for Q3 2026, filed 5 Nov 2026.